Abstract:Background: Xerostomia and changes in saliva characteristics are common side-effects in patients with head and neck cancer (HNC) undergoing radiotherapy, which negatively impact their oral health. However, there are no consensus standards for intervention to manage these problems. The aim of this study was to determine the effect of an integrated supportive program on xerostomia and saliva characteristics at a 1-year follow-up of patients with HNC radiated with a low dose to the major salivary glands. Methods: The CONSORT guidelines for a randomized controlled trial were used. Participants with a low overall dose to major salivary glands were randomly allocated to an intervention group (n = 47) or a control group (n = 45). The intervention group received usual care and an integrated supportive program, which included three steps: face-to-face education; face-to-face coaching at 1 month post-radiotherapy; and four telephone coaching sessions at 2, 3, 6, and 9 months post-radiotherapy. The face-to-face education consisted of oral hygiene instruction, oral self-care strategies, facial and tongue muscle exercises, and salivary gland massage. Adherence to the intervention was evaluated using a questionnaire completed during the 9 months follow-up. The control group received usual care. The unstimulated saliva flow rate and xerostomia were assessed in both groups. Results: A total of 79 participants (40 in the intervention group and 39 in the control group) completed the 12 months follow-up. The intervention group achieved significantly greater relief from xerostomia than the control group after 3 months (intervention group: 35.1 ± 5.9 versus control group: 38.0 ± 5.9, P = 0.027) and 12 months follow-up (intervention group: 18.5 ± 4.1 versus control group: 22.8 ± 4.3, P < 0.001). A higher unstimulated saliva flow rate was observed in the intervention group than the control group at 12 months follow-up (intervention group: 0.16 ± 0.08 versus control group: 0.12 ± 0.07, P = 0.035). Adherence to the intervention was generally good. Conclusion: This integrated supportive program with good adherence relieved xerostomia and had a positive effect on unstimulated saliva flow rate among patients with HNC radiated with a low dose to the major salivary glands during the 12 months of follow-up. Trial registration: Chinese Clinical Trial Registry ChiCTR2100051876 (08/10/2021), retrospectively registered.

Clinical Research on Submandibular Gland Transposition Intervening Acute Radiation-Induced Oral Mucosal Reaction and Xerostomia

[Primary Effect of Submandibular Salivary Gland Transfer in Preventing Radiation-Induced Xerostomia of Nasopharyngeal Carcinoma].

Submandibular Gland Transfer Prevents Radiation-Induced Xerostomia

Oncological Safty Evaluation of Submandibular Salivary Gland Transfer Prevents Radiation-Induced Xerostomia in the Patients with Nasopharyngeal Carcinoma

Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-Year outcomes.

Submandibular Gland Transfer for the Prevention of Postradiation Xerostomia in Patients with Head and Neck Cancer: A Systematic Review and Meta-Analysis

Experimental Study of Rabbit Submandibular Salivary Gland Transfer Prevents Radiation-Induced Xerostomia

The Impact of Submandibular Glands Protection on Xerostomia As Monitored by Diffusion-Weighted Imaging in Nasopharyngeal Carcinoma Patients.

Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.

Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review

Impact of Salivary Gland Dosimetry on Post-Imrt Recovery of Saliva Output and Xerostomia Grade for Head-and-neck Cancer Patients Treated with or Without Contralateral Submandibular Gland Sparing: a Longitudinal Study.

Submandibular gland transfer into the temporal fossa in patients with oral squamous cell carcinoma: A viable option to prevent radiation-induced xerostomia

Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial

Survey on Xerostomia after radiotherapy for the nasopharyngeal carcinoing patients

Magnetic Resonance Sialography for Investigating Major Salivary Gland Duct System after Intensity-Modulated Radiotherapy of Nasopharyngeal Carcinoma

Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial

Sparing Submandibular Gland to Alleviating Acute Xerostomia in Patients with Nasopharyngeal Carcinoma Treated with Helical Tomotherapy: Evaluation by Diffusion Kurtosis Imaging

Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation

Decreased saliva secretion and down-regulation of AQP5 in submandibular gland in irradiated rats.

Clinical Study of the Effect of Reduced Glutathione Injection in Prevention of Acute Radiation Mucositis

Clinical Observation on the Preventive Effect of Recombinant Human Granulocyte Colony Stimulating Factor on Radiation-induced Oral Mucositis